Indivior Shares Outstanding 2012-2019 | INVVY

Indivior shares outstanding from 2012 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Indivior Annual Shares Outstanding
(Millions of Shares)
2018 145
2017 144
2016 149
2015 147
2014 145
2013 145
2012
2011
Indivior Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 151
Q4 2018 145
Q3 2018 150
Q2 2018 150
Q1 2018 150
Q4 2017 144
Q3 2017 150
Q2 2017 150
Q1 2017 150
Q4 2016 149
Q3 2016 149
Q2 2016 149
Q1 2016 146
Q4 2015 147
Q3 2015 147
Q2 2015 147
Q1 2015 145
Q4 2014
Q3 2014 145
Q2 2014 145
Q4 2013
Q4 2012
Q4 2011
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.369B $0.785B
Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.031B 37.04
Takeda Pharmaceutical (TAK) Japan $56.514B 10.02
Astellas Pharma (ALPMY) Japan $30.561B 15.26
Eisai (ESALY) Japan $22.212B 42.82
UCB SA (UCBJF) Belgium $18.867B 0.00
Grifols, S.A (GRFS) Spain $16.845B 22.07
Merck (MKGAF) Germany $16.330B 22.28
Ono Pharmaceutical (OPHLF) Japan $11.311B 24.18
Neurocrine Biosciences (NBIX) United States $8.702B 241.77
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $8.012B 32.96
Ionis Pharmaceuticals (IONS) United States $7.779B 15.76
Jazz Pharmaceuticals (JAZZ) Ireland $7.199B 8.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
IPSEN SA ADR (IPSEY) France $5.849B 0.00
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.137B 15.63
United Therapeutics (UTHR) United States $4.952B 0.00
Nektar Therapeutics (NKTR) United States $3.897B 0.00
FibroGen (FGEN) United States $3.748B 110.15
Evotec AG (EVTCY) Germany $3.575B 57.69
Arrowhead Pharmaceuticals (ARWR) United States $3.468B 64.38
Sage Therapeutics (SAGE) United States $3.340B 0.00
PTC Therapeutics (PTCT) United States $3.255B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.816B 11.39
ChemoCentryx (CCXI) United States $2.692B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.020B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.945B 53.19
Xencor (XNCR) United States $1.820B 74.63
Ironwood Pharmaceuticals (IRWD) United States $1.750B 21.27
Heron Therapeutics (HRTX) United States $1.724B 0.00
Tilray (TLRY) Canada $1.665B 0.00
Corcept Therapeutics (CORT) United States $1.524B 17.05
Endo (ENDP) Ireland $1.481B 2.72
USANA Health Sciences (USNA) United States $1.440B 15.05
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.424B 9.71
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.309B 0.00
Zogenix (ZGNX) United States $1.239B 0.00
Akebia Therapeutics (AKBA) United States $1.059B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.013B 31.40
Portola Pharmaceuticals (PTLA) United States $0.984B 0.00
Karyopharm Therapeutics (KPTI) United States $0.911B 0.00
Aerie Pharmaceuticals (AERI) United States $0.870B 0.00
Radius Health (RDUS) United States $0.826B 0.00
Collegium Pharmaceutical (COLL) United States $0.772B 0.00
ImmunoGen (IMGN) United States $0.716B 0.00
Flexion Therapeutics (FLXN) United States $0.620B 0.00
Molecular Templates (MTEM) United States $0.620B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.524B 0.00
TherapeuticsMD (TXMD) United States $0.502B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.467B 56.63
Ardelyx (ARDX) United States $0.460B 0.00
Innate Pharma SA (IPHYF) France $0.446B 0.00
Translate Bio (TBIO) United States $0.437B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.431B 18.59
Aptorum Group (APM) Hong Kong, SAR China $0.417B 0.00
Organogenesis Holdings (ORGO) United States $0.412B 0.00
Calithera Biosciences (CALA) United States $0.391B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.383B 0.00
Siga Technologies (SIGA) United States $0.375B 8.57
Lannett Co Inc (LCI) United States $0.363B 5.84
Rigel Pharmaceuticals (RIGL) United States $0.360B 0.00
DURECT (DRRX) United States $0.358B 0.00
Harpoon Therapeutics (HARP) United States $0.357B 0.00
Recro Pharma (REPH) United States $0.352B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.336B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.334B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.324B 0.00
Concert Pharmaceuticals (CNCE) United States $0.322B 0.00
Rafael Holdings (RFL) United States $0.309B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.302B 0.00
OptiNose (OPTN) United States $0.280B 0.00
Ocular Therapeutix (OCUL) United States $0.241B 0.00
KalVista Pharmaceuticals (KALV) United States $0.238B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.238B 0.00
MEI Pharma (MEIP) United States $0.233B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.192B 0.00
Taiwan Liposome (TLC) Taiwan $0.190B 0.00
Jounce Therapeutics (JNCE) United States $0.185B 2.48
Matinas Biopharma Holdings (MTNB) United States $0.184B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 31.17
IMV INC (IMV) Canada $0.146B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.118B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.117B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Xeris Pharmaceuticals (XERS) United States $0.109B 0.00
CannTrust Holdings (CTST) Canada $0.108B 0.00
Otonomy (OTIC) United States $0.102B 0.00
Aquestive Therapeutics (AQST) United States $0.101B 0.00
Redhill Biopharma (RDHL) Israel $0.099B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
CV Sciences (CVSI) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.076B 0.00
Infinity Pharmaceuticals (INFI) United States $0.074B 0.00
MediWound (MDWD) Israel $0.073B 0.00
Onconova Therapeutics (ONTX) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.064B 19.27
CTI BioPharma (CTIC) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
VAXART, INC (VXRT) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
Nivalis Therapeutics (ALPN) United States $0.057B 0.00
Aclaris Therapeutics (ACRS) United States $0.057B 0.00
IsoRay (ISR) United States $0.055B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.050B 22.81
Opiant Pharmaceuticals (OPNT) United States $0.050B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.046B 0.00
AgeX Therapeutics (AGE) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Vical (BBI) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Lipocine (LPCN) United States $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Novan (NOVN) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00